CRO Update

Veeda Oncology Announces $8.4 million in New Business

Veeda Oncology, a full service Oncology CRO with facilities in North America, Europe and India, has been awarded over $8.4 million of new clinical research programmes over the past 30 days. The awarded work will be conducted in India, Europe and the United States and will include services for monitoring, data management and biostatistics, medical monitoring, safety, site management and project management. Matt Bowman, President and CEO of Veeda Oncology, stated, "We are enjoying our continued repeat business from our existing clients as well as these five new clients. The feedback from our clients is that they value our focused approach to oncology and our strong execution of programmes, which is due to our team's experience and expertise in oncology."

Veeda Oncology has the unique capability of providing rapid and strong global oncology patient accrual with an effective cost structure in North America, Europe and India. Veeda Oncology is part of Veeda Group, the largest Phase I CRO in India also engaged in early clinical development and Phase IIa clinical research since 2005 having six offices across India, the UK, the US & Europe.

EH News Bureau